Mirae Asset Global Investments Co. Ltd. Boosts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Mirae Asset Global Investments Co. Ltd. grew its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 239.1% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 21,463 shares of the biotechnology company’s stock after buying an additional 15,134 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Axon Enterprise were worth $13,101,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of AXON. Asset Dedication LLC boosted its stake in Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after acquiring an additional 18 shares during the last quarter. Insigneo Advisory Services LLC lifted its stake in Axon Enterprise by 1.4% in the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares during the last quarter. Menard Financial Group LLC lifted its stake in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock valued at $1,204,000 after purchasing an additional 24 shares during the last quarter. PFG Investments LLC grew its holdings in Axon Enterprise by 0.6% during the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares during the period. Finally, Gladstone Institutional Advisory LLC increased its position in Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after buying an additional 26 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on AXON. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Northland Securities upped their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Robert W. Baird lifted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. JMP Securities upped their price target on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research note on Tuesday. Finally, The Goldman Sachs Group lifted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a research note on Monday, January 27th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $542.15.

Axon Enterprise Stock Performance

Shares of AXON opened at $677.40 on Friday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a 50-day moving average price of $622.79 and a 200-day moving average price of $491.30. The company has a market cap of $51.66 billion, a PE ratio of 175.04, a price-to-earnings-growth ratio of 6.54 and a beta of 1.05. Axon Enterprise, Inc. has a 12-month low of $255.68 and a 12-month high of $698.67.

Insider Buying and Selling at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the transaction, the insider now directly owns 154,394 shares of the company’s stock, valued at approximately $91,691,508.72. This trade represents a 12.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock worth $30,721,337 over the last three months. 6.10% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.